Document Detail


Bioavailability of lycopene in the rat: the role of intestinal lymphatic transport.
MedLine Citation:
PMID:  20487215     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: As a natural antioxidant derived from dietary sources, lycopene has attracted considerable attention as a potent chemopreventative agent. Lycopene is an extremely lipophilic compound and absorption from dietary sources is estimated to be low and highly variable. As a result, plasma lycopene concentrations are poorly correlated with dietary intake of lycopene rich food stuffs. The development of an oral formulation remains a challenge that requires a better understanding of the mechanisms involved in the intestinal absorption of this compound.
METHODS: The solubility of lycopene in simulated physiological fluids and bile salt mixed micelle formulations was determined. The extent of intestinal lymphatic transport and the absolute bioavailability of lycopene from a range of biorelevant media was evaluated in a mesenteric lymph duct cannulated anaesthetised rat model.
RESULTS: The absolute bioavailability of lycopene after 8 h was 1.85 +/- 0.39%. The overall extent of the intestinal lymphatic transport was in the range of 0.6-3.4% of the administered dose. A strong positive correlation (r(2) > 0.9) between intestinal lycopene levels and intestinal triglyceride levels was demonstrated.
CONCLUSIONS: The intestinal lymphatic route is the major uptake mechanism of lycopene from the gastrointestinal tract. Lycopene transport in intestinal lymph was closely associated with triglyceride transport in the lymph. Formulation strategies designed to promote intestinal lymphatic uptake, such as lipid-based formulations containing long-chain fatty acids (LCFA) or lecithin, may serve to enhance oral bioavailability of lycopene.
Authors:
Waleed Faisal; Caitriona M O'Driscoll; Brendan T Griffin
Related Documents :
1735365 - Neurotensin prevents intestinal mucosal hypoplasia in rats fed an elemental diet.
20187525 - Basic study on small intestinal motility with various nutrients in supposed post-esopha...
9821815 - Enhancement of the oral bioavailability of phenytoin by n-acetylation and absorptive ch...
3351735 - A model to study the direct effect of diet on early intestinal growth and maturation us...
20156465 - Physiological variables explain mineral intake in iberian red deer.
15657475 - Food and macronutrient intake of elite kenyan distance runners.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of pharmacy and pharmacology     Volume:  62     ISSN:  2042-7158     ISO Abbreviation:  J. Pharm. Pharmacol.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-05-21     Completed Date:  2010-09-10     Revised Date:  2011-09-13    
Medline Journal Info:
Nlm Unique ID:  0376363     Medline TA:  J Pharm Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  323-31     Citation Subset:  IM    
Affiliation:
School of Pharmacy, University College Cork, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Biological Transport
Carotenoids / administration & dosage,  isolation & purification,  metabolism*
Catheterization
Dietary Fats / metabolism
Emulsions / metabolism
Fatty Acids / metabolism
Intestinal Absorption
Intestines / physiology*
Kinetics
Lymph / metabolism
Lymphatic System / physiology*
Lymphatic Vessels
Male
Rats
Rats, Wistar
Solubility
Triglycerides / metabolism
Chemical
Reg. No./Substance:
0/Dietary Fats; 0/Emulsions; 0/Fatty Acids; 0/Triglycerides; 36-88-4/Carotenoids; 502-65-8/lycopene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Regional variations of vasomotion to G-protein coupled receptor agonists following heat stress in ra...
Next Document:  Recombinant bovine pancreatic trypsin inhibitor protects the liver from carbon tetrachloride-induced...